about
Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South AfricaImpact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countriesRisk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort studyDiagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational studyMortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosisFeasibility of using Determine TB-LAM to diagnose tuberculosis in HIV-positive patients in programmatic conditions: a multisite studyDistribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi)Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosisHIV epidemic and cascade of care in 12 east African rural fishing communities: results from a population-based survey in Uganda
P50
Q36261370-19082517-787B-4E6C-874F-AA45749F4599Q41926207-BBEAEE8B-FDE9-4AE8-9228-7D35F4765413Q52676754-02003908-C44D-4271-AE1F-BAE596B31A8DQ56908720-2BE779B2-07F2-42A5-B612-D11C85B2F832Q59811540-100E8725-59F5-4856-A212-B05161D58D6CQ63379734-688B6334-A6D7-4074-AC36-E56E0BFC5B4CQ64080150-906A5EAB-397B-46DF-9DAC-079BBF7E636DQ64234973-F5768FBE-E2D8-48CA-B8EA-28B8D1EDAE66Q90698561-79272789-0C03-4207-84D4-C497573A36D6Q91075468-901A4B9B-8F40-49E8-BF8B-74E6355743ACQ93061699-1A489245-C71B-4E59-A6A9-5D59F4FC6002Q96606358-A703797F-3FDC-4AC8-92AB-8DAB180FBB7F
P50
description
researcher (ORCID 0000-0003-0302-9063)
@en
name
Helena Huerga
@en
type
label
Helena Huerga
@en
prefLabel
Helena Huerga
@en
P31
P496
0000-0003-0302-9063